Metabolic effects of the SGLT2 inhibitor dapagliflozin in heart failure across the spectrum of ejection fraction
Selvaraj S, Patel S, Sauer AJ, et al.
Circ Heart Fail. 2024:e011980.
Leggi
Selvaraj S, Patel S, Sauer AJ, et al.
Circ Heart Fail. 2024:e011980.
Leggi
Wang J, Wei Z, Wang Y, et al.
Diabetes Res Clin Pract. 2024:111904.
Leggi
Avari P, Choudhary P, Lumb A, et al.
Diabet Med. Pub. online 21 Oct 2024.
Leggi
Renard E, Weinstock RS, Aleppo G, et al.
Diabetes Care. Pub. online 18 Oct 2024.
Leggi
Hoeg-Jensen T, Kruse T, Brand CL, et al.
Nature. Pub. online 16 Oct 2024.
Leggi
Mordi IR, Li I, George G, et al.
Diabetes Care. Pub. online 16 Oct 2024.
Leggi
Mollace R, Longo S, Nardin M, et al.
Diabetes Res Clin Pract. Pub. online 14 Oct 2024.
Leggi
Apaolaza PS, Chen YC, Grewal K, et al.
Diabetologia. Pub. online 15 Oct 2024.
Leggi
Carlsson LMS, Carlsson B, Jacobson P, et al.
Diabetes Obes Metab. Pub. online 21 Oct 2024.
Leggi
Liu AB, Lin YX, Meng TT, et al.
BMC Endocr Disord. Pub. online 15 Oct 2024.
Leggi